gadolinium oxide has been researched along with glucuronic acid in 2 studies
| Studies (gadolinium oxide) | Trials (gadolinium oxide) | Recent Studies (post-2010) (gadolinium oxide) | Studies (glucuronic acid) | Trials (glucuronic acid) | Recent Studies (post-2010) (glucuronic acid) |
|---|---|---|---|---|---|
| 178 | 1 | 131 | 8,119 | 170 | 4,136 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, MJ; Chae, KS; Chang, Y; Choi, ES; Jung, JC; Kim, JH; Kim, TJ; Lee, GH; Park, JY; Woo, S | 1 |
| Bae, JE; Baeck, JS; Chae, KS; Chang, Y; Kim, CR; Lee, GH | 1 |
2 other study(ies) available for gadolinium oxide and glucuronic acid
| Article | Year |
|---|---|
Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Gadolinium; Glucuronic Acid; Humans; Injections; Magnetic Resonance Imaging; Magnetics; Nanoparticles; Particle Size; Protons; Rats; Spectroscopy, Fourier Transform Infrared; Surface Properties; Thermogravimetry; Water | 2009 |
Ligand-size dependent water proton relaxivities in ultrasmall gadolinium oxide nanoparticles and in vivo T1 MR images in a 1.5 T MR field.
Topics: Animals; Cell Line; Cell Survival; Contrast Media; Gadolinium; Glucuronic Acid; Kidney; Liver; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Particle Size; Radiography | 2014 |